EUCTR2017-002312-13-DK进行中（未招募）1 期
PET/CT imaging of uPAR-expression in patients with neuroendocrine tumors using 68Ga-NOTA-AE105 - PET/CT imaging of uPAR-expression in patients with neuroendocrine tumors using 68Ga-NOTA-AE105
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age > 18 years
- •Diagnosed with gastro-enetero-pancreatic Neuroendocrine Tumors (GEP-NET; grade: G1-G3) or broncho-pulmonary NET.
- •WHO performance status 0-2
- •Must be able to read and understand the patient information in Danish and to give informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 80
排除标准
- •Breast-feeding
- •Weight more than the maximum weight limit for the PET/CT bed of the scanner (140 kg)
- •History of allergic reaction attributable to compounds of similar chemical or biologic composition to 68Ga-NOTA-AE105
- •In case of broncho-pulmonary NET, the subtype must not be small cell lung cancer (SCLC)
研究者
相似试验
已完成
2 期
PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105Neuroendocrine TumorsNCT03278275Rigshospitalet, Denmark116
进行中（未招募）
1 期
uPAR-PET/MRI in patients with prostate cancer for evaluation of tumor aggressivenessProstate cancerEUCTR2017-002276-37-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine & PET52
进行中（未招募）
1 期
Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer 18F-RO6958948Traumatic brain injury (TBI), cerebral haemorrhage (ICH), subarachnoid haemorrhage (SAH) and cerebral commotio.MedDRA version: 21.1Level: PTClassification code 10070976Term: Craniocerebral injurySystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 20.1Level: LLTClassification code 10042320Term: Subarachnoid hemorrhageSystem Organ Class: 100000004852MedDRA version: 20.1Level: LLTClassification code 10060690Term: Traumatic brain injurySystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 21.1Level: LLTClassification code 10022754Term: Intracerebral hemorrhageSystem Organ Class: 100000004852EUCTR2020-002433-15-SERegion Skåne80
进行中（未招募）
1 期
uPAR-PET for prognostication in patients with non-small cell lung cancer, malignant pleural mesothelioma and large cell neuroendocrine carcinoma of the lungon-small cell lung cancer, malignant pleural mesothelioma, large cell neuroendocrine carcinoma of the lungMedDRA version: 18.1Level: PTClassification code 10057270Term: Neuroendocrine carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.1Level: PTClassification code 10059518Term: Pleural mesothelioma malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-005642-59-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET
进行中（未招募）
1 期
Phase II trial: uPAR PET/CT and FDG PET/MRI for determining lymph node metastases in patients with bladder cancerrinary bladder cancerMedDRA version: 19.0Level: LLTClassification code 10005004Term: Bladder cancer NOSSystem Organ Class: 100000004864EUCTR2016-001026-33-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET40